The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...
KALAMAZOO, MI -- Scientists at Western Michigan University Homer Stryker School of Medicine (WMed) have made a ...
Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...
Heart disease and stroke claim more lives in the United States than all forms of cancer and accidental deaths combined, ...
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
A research team at Western Michigan University Homer Stryker M.D. School of Medicine has made a significant discovery.
A team led by Dr. Erik Larson, vice chair of the Department of Biomedical Sciences, has uncovered the cause of a common kidney disease after eight years of research, a news release from WMed said.